Latest Articles
Estrogen Found to Regulate Nesfatin-1 Expression in Endometrial Decidualization Study - geneonline.com
Estrogen Found to Regulate Nesfatin-1 Expression in Endometrial Decidualization Study geneonline.com
Published: Dec. 16, 2025, 7:36 p.m.
Estrogen Boosts Nesfatin-1 for Endometrial Decidualization - Bioengineer.org
Estrogen Boosts Nesfatin-1 for Endometrial Decidualization Bioengineer.org
Published: Dec. 16, 2025, 7:27 p.m.
Estrogen Boosts Nesfatin-1 for Endometrial Decidualization - BIOENGINEER.ORG
Estrogen Boosts Nesfatin-1 for Endometrial Decidualization BIOENGINEER.ORG
Published: Dec. 16, 2025, 7:27 p.m.
Mismatch Repair Deficiency Profiling and Its Impact on Management and Prognosis in Endometrial Cancer Patients: A Comprehensive Update - Cureus
Mismatch Repair Deficiency Profiling and Its Impact on Management and Prognosis in Endometrial Cancer Patients: A Comprehensive Update Cureus
Published: Dec. 16, 2025, 12:29 p.m.
Endometrial cancer treatment enters a paradigm shift: expert - koreabiomed.com
Endometrial cancer treatment enters a paradigm shift: expert koreabiomed.com
Published: Dec. 16, 2025, 8:01 a.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
Endometrial Organoids Open a Window into the Womb - the-scientist.com
Endometrial Organoids Open a Window into the Womb the-scientist.com
Published: Dec. 15, 2025, 5:15 a.m.
Study Links Endometrial Cell Senescence and Recurrent Spontaneous Abortion to UCP2 and GSR Biomarkers - geneonline.com
Study Links Endometrial Cell Senescence and Recurrent Spontaneous Abortion to UCP2 and GSR Biomarkers geneonline.com
Published: Dec. 12, 2025, 9:41 p.m.
George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia - Contemporary OB/GYN
George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia Contemporary OB/GYN
Published: Dec. 12, 2025, 2:26 p.m.
Link copied to clipboard!